A randomized trial of tacrolimus versus tacrolimus and prednisone for the maintenance of disease remission in noninfectious uveitis

Ophthalmology

Volumn 119, Issue 6, 2012, Pages 1223-1230

  Lee, Richard W J ^a,b   Greenwood, Rosemary ^c   Taylor, Hazel ^c   Amer, Radgonde ^d,e   Biester, Sabine ^d,e   Heissigerova, Jarka ^d,e   Forrester, John V ^d,e   Dick, Andrew D ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL EYE HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PREDNISONE; TACROLIMUS;

ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG HYPERSENSITIVITY; DRUG TREATMENT FAILURE; HEADACHE; HUMAN; LETHARGY; MAINTENANCE THERAPY; MEAN ARTERIAL PRESSURE; MONOTHERAPY; MUSCLE CRAMP; MUSCULOSKELETAL PAIN; PARESTHESIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SIDE EFFECT; TREMOR; URINARY FREQUENCY; UROGENITAL TRACT INFECTION; UVEITIS; VISUAL ACUITY;

ADMINISTRATION, ORAL; ADULT; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAINTENANCE CHEMOTHERAPY; MALE; PREDNISONE; REMISSION INDUCTION; TACROLIMUS; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY;

EID: 84861913547     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.12.030     Document Type: Article

References (34)

1. D.A. Jabs Epidemiology of uveitis Ophthalmic Epidemiol 15 2008 283 284
2. M.S. Suttorp-Schulten, A. Rothova The possible impact of uveitis in blindness: a literature survey Br J Ophthalmol 80 1996 844 848
3. C.C. Murphy, E.H. Hughes, N.A. Frost, A.D. Dick Quality of life and visual function in patients with intermediate uveitis Br J Ophthalmol 89 2005 1161 1165
4. A.D. Dick, J.V. Forrester, A.A. Okada Practical Manual of Intraocular Inflammation 2008 Informa Healthcare New York 17 122
5. A.A. Okada Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature Ocul Immunol Inflamm 13 2005 335 351
6. H.E. Kaufman Ocular inflammatory disease N Engl J Med 270 1964 456 463
7. D.A. Jabs, J.T. Rosenbaum, C.S. Foster Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel Am J Ophthalmol 130 2000 492 513
8. T. Rhen, J.A. Cidlowski Antiinflammatory action of glucocorticoids - new mechanisms for old drugs N Engl J Med 353 2005 1711 1723
9. Standardization of Uveitis Nomenclature (SUN) Working Group Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop Am J Ophthalmol 140 2005 509 516
10. R.O. Kacmaz, J.H. Kempen, C. Newcomb Cyclosporine for ocular inflammatory diseases Ophthalmology 117 2010 576 584
11. S.C. Teoh, A.C. Hogan, A.D. Dick, R.W. Lee Mycophenolate mofetil for the treatment of uveitis Am J Ophthalmol 146 2008 752 760
12. J.J. Augustine, D.E. Hricik Steroid sparing in kidney transplantation: changing paradigms, improving outcomes, and remaining questions Clin J Am Soc Nephrol 1 2006 1080 1089
13. T. Kino, H. Hatanaka, S. Miyata FK-506, a novel immunosuppressant isolated from a Streptomyces II. Immunosuppressive effect of FK-506 in vitro J Antibiot (Tokyo) 40 1987 1256 1265
14. D.H. Peters, A. Fitton, G.L. Plosker, D. Faulds Tacrolimus: a review of its pharmacology, and therapeutic potential in hepatic and renal transplantation Drugs 46 1993 746 794
15. J.G. O'Grady, A. Burroughs, P. Hardy UK and Republic of Ireland Liver Transplant Study Group Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial Lancet 360 2002 1119 1125
16. S.C. Jensik FK 506 Kidney Transplant Study Group Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial Transplant Proc 30 1998 1216 1218
17. B.P. Griffith, K. Bando, R.L. Hardesty A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation Transplantation 57 1994 848 851
18. G. Ligtenberg, R.J. Hene, P.J. Blankestijn, H.A. Koomans Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus J Am Soc Nephrol 12 2001 368 373
19. S.C. Textor, R. Wiesner, D.J. Wilson Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients Transplantation 55 1993 1332 1339
20. C.C. Murphy, K. Greiner, J. Plskova Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis Arch Ophthalmol 123 2005 634 641
21. A.C. Hogan, C.E. McAvoy, A.D. Dick, R.W. Lee Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis Ophthalmology 114 2007 1000 1006
22. A.A. van Everdingen, J.W. Jacobs, D.R. Siewertsz Van Reesema, J.W. Bijlsma Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial Ann Intern Med 136 2002 1 12
23. S. Vitko, M. Klinger, K. Salmela Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study Transplantation 80 2005 1734 1741
24. O. Boillot, D.A. Mayer, K. Boudjema Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study Liver Transpl 11 2005 61 67
25. S.A. Lubitz, D.A. Baran, M.M. Alwarshetty Long-term results of tacrolimus monotherapy in cardiac transplant recipients J Heart Lung Transplant 25 2006 699 706
26. J.V. Forrester, A.A. Okada, B. BenEzra, S. Ohno Posterior Segment Intraocular Inflammation: Guidelines 1998 Kugler The Hague 174 178
27. D.A. Rosser, S.N. Cousens, I.E. Murdoch How sensitive to clinical change are ETDRS logMAR visual acuity measurements? Invest Ophthalmol Vis Sci 44 2003 3278 3281
28. G. Piaggio, D.R. Elbourne, D.G. Altman CONSORT Group Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement JAMA 295 2006 1152 1160
29. D.A. Jabs Improving the reporting of clinical case series Am J Ophthalmol 139 2005 900 905
30. CONSORT Group K.F. Schulz, D.G. Altman, D. Moher CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials [report online] BMJ 340 2010 c332 http://www.bmj.com/content/340/bmj.c332?view= long&pmid=20332509 Accessed November 23, 2011
31. D.J. Kilmartin, Z.J. Fletcher, J.A. Almeida CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis Invest Ophthalmol Vis Sci 42 2001 1285 1292
32. M. Mochizuki, K. Masuda, T. Sakane A clinical trial of FK506 in refractory uveitis Am J Ophthalmol 115 1993 763 769
33. M. Ishioka, S. Ohno, S. Nakamura FK506 treatment of noninfectious uveitis Am J Ophthalmol 118 1994 723 729
34. S. Friemann, E. Feuring, W. Padberg, W. Ernst Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus Transplant Proc 30 1998 1240 1242